Background:

• 2005-Pre Associate Professor, Department of Chemistry and Biochemistry Program, Indiana University, Bloomington, IN
• 2002-2004 Head, Global Drug Discovery and Development Statistics and Information Sciences, Eli Lilly and Company, Indianapolis, IN
• 1994-2002 Senior Research Scientist, Structural Biology and Drug Design, Eli Lilly and Company, Indianapolis, IN
• 1992-1994 Research Faculty Member, Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX
• 1990-1992 Postdoctoral Fellow, Structural Biology, Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX
• 1989-1990 Visiting Scientist, High resolution protein crystallography, Photon Factory, Japan
• 1997 Global R&D Community Award, Eli Lilly and Co.
• 1999 Lilly Research Lab President's Recognition Award, Eli Lilly and Co.
• 1990-192 Welch Foundation Fellowship Award

Professor Zhang's research interests are in biochemistry, chemical genomics, computational chemistry, and structure-based drug design. The Zhang group will solve crystal structures of protein complexes in fat cell signaling and tumor angiogenesis pathways to aid the design of anti-obesity and anti-cancer drugs.

Selected Publications:

Hamdouchi C, Zhong B, Mendoza J, Zhang F et al. (2005), Structure-Based Design of a New Class of Highly Selective Aminoimidazo[1,2-]pyridine-Based Inhibitors of Cyclin Dependent Kinases, bioorganic & Medicinal Chemistry Letters.

Jaramillo C, Zhang F. et al (2004), Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation, bioorganic & Medicinal Chemistry Letters.

J. Singh, J. Yingling, Zhang F, et al (2004), Transforming the TGF- pathway: Convergence of distinct lead generation strategies on a novel kinase pharmcophroe for TbRI, Current Opinion in Drug Discovery and Development 7(4): 10-20.

Al-Awar RS, Ray JE, Zhang F. etal (2004). Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors. Bioorg Med Chem Lett. 14(15): 3925-8.

Sawyer JS, Beight DW, Zhang F, Yingling JM (2004). Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. Bioorg Med Chem Lett. 14(13): 3581-4.

Hadouchi C, Keyser H, Zhang F, Brooks H, et al (2004). The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo(1,2-a]pyridines. Molecular Cancer Therapeutics. 3(1):1-9

Vincent J.-P, Johnson RB, Parsons S, Zhang F, Wang QM (2003). Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis. J. Virology. 77: 9020-9028

Sanchez-Martinez C, Shih C, Zhu G, Dempsey JA, Zhang F (2003) . Studies on Cyclin Dependent Kinase Inhibitors:Indolo[2,3-a]pyrrolo[3,4-c]carbazoles versus Bis-indolylmaleimides, Bioorganic & Medicinal Chemistry Letters 13:3841-3846.

Vieth M, Brooks H, Hamdouchi C, McMillen W, Sawyer JS, Yingling J, and Zhang F(2003). Combining Medicinal Chemistry with Chemogenomic and Computer-Aided Structure-Based Design in Development of Novel Kinase Inhibitors, Cell. Mol. Biol. Lett 8 (2A):566-567

Sawyer JS, Herron DK, Edward CR, Zhang F, and Yingling J (2003). Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-beta Type I Receptor Kinase Domain. Journal of Medicinal Chemistry 46 (19):3953-3956.

Wang QM, Hockman M, Staschke K, Zhang F, Parsons S (2002). Oligomerization and Cooperative RNA Synthesis Activity of HCV RNA-Dependent RNA Polymerase, J. Virology. 76:3865-3872

Jin L, Briggs S, Clawson D, Schevitz R, Smiley D, Tashjian A, Zhang F (2000). "Crystal Structure of Human Parathyroid Hormone 1-34 at 0.9 Å Resolution", J. Biol. Chem. 275:27238-27244.

Zhang F, Basinski M, DiMarchi RD et al. (1997) "Crystal Structure of the Obese Protein Leptin-E100", Nature 387:206-209

Zhang J, Zhang F, Ebert D, Cobb MH, and Goldsmith EJ(1995) "Activity of the MAP Kinase ERK2 is Controlled by a Flexible Surface Loop", Structure 3:299-307.

Zhang F, Strand A, Robbins D, Cobb MH, and Goldsmith EJ (1994) "Crystal Structure of MAP kinase ERK2 at 2.3Å Resolution". Nature. 367: 704-711.

Zhang F, Robbins D, Cobb MH and Goldsmith EJ (1993) " Crystallization and Preliminary X-ray Studies of Extracellular Signal-regulated Kinase-2/MAP kinase with an Incorporated His-tag". J. Mol.Biol. 233: 550-552.

Lin Z, Li J , Zhang F and Tsou C-L (1993) "Structure of D-Glyceraldehyde-3-phosphate Dehydrogenase from Palinurus Versicolor Carrying the fluorescent NAD Derivatives at 2.7 Å Resolution" Arch. Biochem. Biophy. 302:161-166.

Zhang F, Kobe B, Stewart CB, Rutter W and Goldsmith EJ (1991) " Structural Evolution of an Enzyme Specificity: The Structure of Rat Carboxypeptidase A2 at 1.9 Å Resolution". J. Biol. Chem. 266: 24606-24612.